Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

Cabezón T, Gromova I, Gromov P, Serizawa R, Timmermans Wielenga V, Kroman N, Celis JE, Moreira JM.

Mol Cell Proteomics. 2013 Feb;12(2):381-94. doi: 10.1074/mcp.M112.019786. Epub 2012 Nov 20.

2.

Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Moreira JM, Cabezón T, Gromova I, Gromov P, Timmermans-Wielenga V, Machado I, Llombart-Bosch A, Kroman N, Rank F, Celis JE.

Mol Oncol. 2010 Dec;4(6):539-61. doi: 10.1016/j.molonc.2010.09.005. Epub 2010 Oct 8.

3.

Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE.

Mol Oncol. 2010 Feb;4(1):65-89. doi: 10.1016/j.molonc.2009.11.003. Epub 2009 Nov 23.

4.

Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Celis JE, Cabezón T, Moreira JM, Gromov P, Gromova I, Timmermans-Wielenga V, Iwase T, Akiyama F, Honma N, Rank F.

Mol Oncol. 2009 Jun;3(3):220-37. doi: 10.1016/j.molonc.2009.01.005. Epub 2009 Feb 3.

5.

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.

Celis JE, Gromov P, Cabezón T, Moreira JM, Friis E, Jirström K, Llombart-Bosch A, Timmermans-Wielenga V, Rank F, Gromova I.

Mol Cell Proteomics. 2008 Oct;7(10):1795-809. doi: 10.1074/mcp.R800011-MCP200. Epub 2008 Jul 16.

6.

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans-Wielenga V, Rank F, Moreira JM.

Mol Oncol. 2007 Dec;1(3):321-49. doi: 10.1016/j.molonc.2007.09.004. Epub 2007 Sep 25.

7.

Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro.

Birkenkamp-Demtroder K, Mansilla F, Sørensen FB, Kruhøffer M, Cabezón T, Christensen LL, Aaltonen LA, Verspaget HW, Ørntoft TF.

Mol Oncol. 2007 Sep;1(2):181-95. doi: 10.1016/j.molonc.2007.05.005. Epub 2007 Jun 3.

8.

Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.

Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N.

Int J Cancer. 2007 Oct 1;121(7):1433-44.

9.

Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F.

Mol Oncol. 2007 Jun;1(1):97-119. doi: 10.1016/j.molonc.2007.02.005. Epub 2007 Mar 14.

10.

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, Friis E, Rank F.

FEBS Lett. 2006 May 22;580(12):2935-44. Epub 2006 Apr 12. Review.

11.

Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.

Celis JE, Gromov P, Moreira JM, Cabezón T, Friis E, Vejborg IM, Proess G, Rank F, Gromova I.

Mol Cell Proteomics. 2006 Mar;5(3):462-83. Epub 2005 Nov 28.

13.

Human FK506 binding protein 65 is associated with colorectal cancer.

Olesen SH, Christensen LL, Sørensen FB, Cabezón T, Laurberg S, Orntoft TF, Birkenkamp-Demtröder K.

Mol Cell Proteomics. 2005 Apr;4(4):534-44. Epub 2005 Jan 25.

14.

Towards discovery-driven translational research in breast cancer.

Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P.

FEBS J. 2005 Jan;272(1):2-15. Review.

15.

Impact of proteomics on bladder cancer research.

Celis JE, Gromova I, Moreira JM, Cabezon T, Gromov P.

Pharmacogenomics. 2004 Jun;5(4):381-94. Review.

PMID:
15165174
16.

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I.

Mol Cell Proteomics. 2004 Apr;3(4):327-44. Epub 2004 Jan 30.

17.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, Grigorian M, Lukanidin E, Thor Straten P, Guldberg P, Bartkova J, Bartek J, Lukas J, Lukas C, Lykkesfeldt A, Jäättelä M, Roepstorff P, Bolund L, Ørntoft T, Brünner N, Overgaard J, Sandelin K, Blichert-Toft M, Mouridsen H, Rank FE.

Mol Cell Proteomics. 2003 Jun;2(6):369-77. Epub 2003 Jun 25.

18.

The Rib and alpha proteins define a family of group B streptococcal surface proteins that confer protective immunity.

Wästfelt M, Stålhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G.

Adv Exp Med Biol. 1997;418:619-22. No abstract available.

PMID:
9331728
19.

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.

Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15394-9.

20.

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.

Shimizu YK, Igarashi H, Kiyohara T, Cabezon T, Farci P, Purcell RH, Yoshikura H.

Virology. 1996 Sep 15;223(2):409-12.

21.

Identification of a family of streptococcal surface proteins with extremely repetitive structure.

Wästfelt M, Stâlhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G.

J Biol Chem. 1996 Aug 2;271(31):18892-7.

22.

Immunoelectron microscopic detection of the hepatitis B virus major surface protein in dilated perinuclear membranes of yeast cells.

Biemans R, Thines D, Petre-Parent B, De Wilde M, Rutgers T, Cabezon T.

DNA Cell Biol. 1992 Oct;11(8):621-6.

PMID:
1388733
23.

Subcellular localization of recombinant truncated Gag precursor proteins of HIV expressed in Saccharomyces cerevisiae.

Biemans R, Thines D, Gheysen D, Rutgers T, Cabezon T.

AIDS. 1992 Jun;6(6):541-6.

PMID:
1388874
24.

The large surface protein of hepatitis B virus is retained in the yeast endoplasmic reticulum and provokes its unique enlargement.

Biemans R, Thines D, Rutgers T, De Wilde M, Cabezon T.

DNA Cell Biol. 1991 Apr;10(3):191-200.

PMID:
2012679
25.

Sequence analysis of the putative structural genes of hepatitis C virus from Japanese and European origin.

Delisse AM, Descurieux M, Rutgers T, D'Hondt E, De Wilde M, Arima T, Barrera-Sala JM, Ercilla MG, Ruelle JL, Cabezon T.

J Hepatol. 1991;13 Suppl 4:S20-3.

PMID:
1668328
26.

Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis.

Delisse-Gathoye AM, Locht C, Jacob F, Raaschou-Nielsen M, Heron I, Ruelle JL, de Wilde M, Cabezon T.

Infect Immun. 1990 Sep;58(9):2895-905.

27.

Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae.

Jacobs E, Rutgers T, Voet P, Dewerchin M, Cabezon T, de Wilde M.

Gene. 1989 Aug 15;80(2):279-91.

PMID:
2555260
28.

Development of a hepatitis B vaccine from transformed yeast cells.

Pêtre J, Van Wijnendaele F, De Neys B, Conrath K, Van Opstal O, Hauser P, Rutgers T, Cabezon T, Capiau C, Harford N, et al.

Postgrad Med J. 1987;63 Suppl 2:73-81.

PMID:
3317362
29.

Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen.

Harford N, Cabezon T, Colau B, Delisse AM, Rutgers T, De Wilde M.

Postgrad Med J. 1987;63 Suppl 2:65-70.

PMID:
3317360
30.

High-level production and isolation of human recombinant alpha 1-proteinase inhibitor in yeast.

Hoylaerts M, Weyens A, Bollen A, Harford N, Cabezón T.

FEBS Lett. 1986 Aug 11;204(1):83-7.

31.

Expression of cloned human haptoglobin and alpha 1-antitrypsin complementary DNAs in Saccharomyces cerevisiae.

van der Straten A, Falque JC, Loriau R, Bollen A, Cabezón T.

DNA. 1986 Apr;5(2):129-36.

PMID:
3519135
32.

Production in yeast of hepatitis B surface antigen by R-DNA technology.

De Wilde M, Cabezon T, Harford N, Rutgers T, Simoen E, Van Wijnendaele F.

Dev Biol Stand. 1985;59:99-107.

PMID:
4007280
33.

Expression of human alpha 1-antitrypsin cDNA in the yeast Saccharomyces cerevisiae.

Cabezón T, De Wilde M, Herion P, Loriau R, Bollen A.

Proc Natl Acad Sci U S A. 1984 Nov;81(21):6594-8.

34.

Characterization of human haptoglobin cDNAs coding for alpha 2FS beta and alpha 1S beta variants.

van der Straten A, Herzog A, Cabezón T, Bollen A.

FEBS Lett. 1984 Mar 12;168(1):103-7.

35.

Molecular cloning of human haptoglobin cDNA: evidence for a single mRNA coding for alpha 2 and beta chains.

vander Straten A, Herzog A, Jacobs P, Cabezón T, Bollen A.

EMBO J. 1983;2(6):1003-7.

36.

Expression of hepatitis B surface antigen in yeast.

Harford N, Cabezon T, Crabeel M, Simoen E, Rutgers A, De Wilde M.

Dev Biol Stand. 1983;54:125-30.

PMID:
6653884
37.

Polarity of amber mutations in ribosomal protein genes of Escherichia coli.

Cabezón T, Delcuve G, Faelen M, Desmet L, Bollen A.

J Bacteriol. 1980 Jan;141(1):41-51.

38.

Ribosomal assembly defectivity in a set of amber mutants of Escherichia coli.

Denicourt D, Delcuve G, Cabezón T, Bollen A.

Biochem Biophys Res Commun. 1979 Jul 12;89(1):91-7. No abstract available.

PMID:
383078
39.

A missense mutation in the gene coding for ribosomal protein S17 (rpsQ) leading to ribosomal assembly defectivity in Escherichia coli.

Herzog A, Yaguchi M, Cabezón T, Corchuelo MC, Petre J, Bollen A.

Mol Gen Genet. 1979 Mar 9;171(1):15-22.

PMID:
108517
41.

Phage Mu-1 mediated transposition: a tool to study the organization of ribosomal protein genes in Escherichia coli.

Cabezón T, Gijsegem FV, Toussaint A, Faelen M, Bollen A.

Mol Gen Genet. 1978 May 31;161(3):291-6.

PMID:
353516
42.

Amber mutations in Escherichia coli essential genes: isolation of mutants affected in the ribosomes.

Delcuve G, Cabezón T, Ghysen A, Herzog A, Bollen A.

Mol Gen Genet. 1977 Nov 29;157(2):149-53.

PMID:
340921
43.

Ribosomal assembly deficiency in an Escherichia coli thermosensitive mutant having an altered L24 ribosomal protein.

Cabezón T, Herzog A, Petre J, Yaguchi M, Bollen A.

J Mol Biol. 1977 Nov 5;116(3):361-74. No abstract available.

PMID:
338919
44.

Translational fidelity in Escherichia coli: contrasting role of neaA and ramA gene products in the ribosome functioning.

Topisirovic L, Villarroel R, De Wilde M, Herzog A, Cabezón T, Bollen A.

Mol Gen Genet. 1977 Feb 28;151(1):89-94.

PMID:
325371
45.

Characterization of conditionallly lethal mutations affecting ribosomal proteins in Escherichia coli [proceedings].

Cabezón T, Delcuve G, Herzog A, Petre J, Bollen A.

Biochem Soc Trans. 1977;5(4):958-9. No abstract available.

PMID:
334601
46.

[Genetics and biochemistry of the bacterial ribosome].

De Wilde M, Cabezón T, Herzog A, Bollen A.

Biochimie. 1977;59(2):125-40. Review. French. No abstract available.

PMID:
322729
47.

Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. II. Localization of the amino acid replacement in protein S17 from a meaA mutant.

Yaguchi M, Wittmann HG, Cabezón T, DeWilde M, Villarroel R, Herzog A, Bollen A.

J Mol Biol. 1976 Jul 5;104(3):617-20. No abstract available.

PMID:
781296
48.

Nomenclature and location of bacterial mutations modifying the frequency of lysogenization of E. coli by lambdoid phages.

Lecocq JP, Dambly C, Lathe R, Babinet C, Bailone A, Devoret R, Gathoye AM, Garcia H, De Wilde M, Cabezon T.

Mol Gen Genet. 1976 Apr 23;145(1):63-4. No abstract available.

PMID:
775310
49.
50.

Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. I. General properties of neaA mutants.

Bollen A, Cabezón T, de Wilde M, Villarroel R, Herzog A.

J Mol Biol. 1975 Dec 25;99(4):795-806. No abstract available.

PMID:
765484

Supplemental Content

Loading ...
Support Center